nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A11—forebrain—attention deficit hyperactivity disorder	0.0656	0.135	CbGeAlD
Dapagliflozin—SLC5A11—midbrain—attention deficit hyperactivity disorder	0.0433	0.0889	CbGeAlD
Dapagliflozin—SLC5A4—nervous system—attention deficit hyperactivity disorder	0.0392	0.0805	CbGeAlD
Dapagliflozin—SLC5A4—central nervous system—attention deficit hyperactivity disorder	0.0378	0.0775	CbGeAlD
Dapagliflozin—SLC5A11—nervous system—attention deficit hyperactivity disorder	0.0356	0.0731	CbGeAlD
Dapagliflozin—SLC5A1—cardiovascular system—attention deficit hyperactivity disorder	0.0351	0.072	CbGeAlD
Dapagliflozin—SLC5A11—central nervous system—attention deficit hyperactivity disorder	0.0343	0.0704	CbGeAlD
Dapagliflozin—SLC5A11—cerebellum—attention deficit hyperactivity disorder	0.0335	0.0688	CbGeAlD
Dapagliflozin—UGT2B4—cardiovascular system—attention deficit hyperactivity disorder	0.0323	0.0664	CbGeAlD
Dapagliflozin—SLC5A4—brain—attention deficit hyperactivity disorder	0.03	0.0615	CbGeAlD
Dapagliflozin—SLC5A4—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0286	0.0558	CbGpPWpGaD
Dapagliflozin—SLC5A11—brain—attention deficit hyperactivity disorder	0.0272	0.0559	CbGeAlD
Dapagliflozin—SLC5A1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0217	0.0423	CbGpPWpGaD
Dapagliflozin—SLC5A2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0217	0.0423	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0197	0.0385	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0151	0.0295	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0144	0.0281	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.0122	0.0238	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.011	0.0215	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0109	0.0213	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0109	0.0213	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.0109	0.0213	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.01	0.0196	CbGpPWpGaD
Dapagliflozin—UGT2B7—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00961	0.0188	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00957	0.0187	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00892	0.0174	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00835	0.0163	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00835	0.0163	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00795	0.0155	CbGpPWpGaD
Dapagliflozin—UGT1A9—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00781	0.0152	CbGpPWpGaD
Dapagliflozin—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00771	0.0158	CbGeAlD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00732	0.0143	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00698	0.0136	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00687	0.0134	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00676	0.0132	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00676	0.0132	CbGpPWpGaD
Dapagliflozin—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00637	0.0131	CbGeAlD
Dapagliflozin—CYP2A6—brain—attention deficit hyperactivity disorder	0.00626	0.0129	CbGeAlD
Dapagliflozin—SLC5A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00602	0.0118	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00602	0.0118	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00602	0.0117	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00593	0.0116	CbGpPWpGaD
Dapagliflozin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00565	0.0116	CbGeAlD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00554	0.0108	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00554	0.0108	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00529	0.0103	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00529	0.0103	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00501	0.00977	CbGpPWpGaD
Dapagliflozin—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00458	0.00893	CbGpPWpGaD
Dapagliflozin—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00449	0.00875	CbGpPWpGaD
Dapagliflozin—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00425	0.00871	CbGeAlD
Dapagliflozin—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00409	0.00839	CbGeAlD
Dapagliflozin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00406	0.00834	CbGeAlD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0038	0.00741	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0038	0.00741	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00349	0.00681	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00347	0.00677	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00344	0.00672	CbGpPWpGaD
Dapagliflozin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00344	0.00705	CbGeAlD
Dapagliflozin—UGT2B4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00342	0.00667	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—STUB1—attention deficit hyperactivity disorder	0.00337	0.00657	CbGpPWpGaD
Dapagliflozin—CYP1A1—brain—attention deficit hyperactivity disorder	0.00325	0.00666	CbGeAlD
Dapagliflozin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00312	0.00639	CbGeAlD
Dapagliflozin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00307	0.00629	CbGeAlD
Dapagliflozin—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00304	0.00593	CbGpPWpGaD
Dapagliflozin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.003	0.00616	CbGeAlD
Dapagliflozin—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00296	0.00577	CbGpPWpGaD
Dapagliflozin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00295	0.00606	CbGeAlD
Dapagliflozin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00289	0.00592	CbGeAlD
Dapagliflozin—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00286	0.00558	CbGpPWpGaD
Dapagliflozin—UGT2B7—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.0027	0.00527	CbGpPWpGaD
Dapagliflozin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00268	0.0055	CbGeAlD
Dapagliflozin—SLC5A1—Disease—STUB1—attention deficit hyperactivity disorder	0.00255	0.00498	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—STUB1—attention deficit hyperactivity disorder	0.00255	0.00498	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00255	0.00497	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00242	0.00473	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00238	0.00464	CbGpPWpGaD
Dapagliflozin—CYP2D6—brain—attention deficit hyperactivity disorder	0.00234	0.00481	CbGeAlD
Dapagliflozin—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00229	0.00447	CbGpPWpGaD
Dapagliflozin—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00221	0.00431	CbGpPWpGaD
Dapagliflozin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00221	0.00453	CbGeAlD
Dapagliflozin—UGT1A9—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00219	0.00428	CbGpPWpGaD
Dapagliflozin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00212	0.00436	CbGeAlD
Dapagliflozin—UGT2B7—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00212	0.00413	CbGpPWpGaD
Dapagliflozin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00208	0.00426	CbGeAlD
Dapagliflozin—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00194	0.00378	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00193	0.00377	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00193	0.00376	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00193	0.00376	CbGpPWpGaD
Dapagliflozin—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00185	0.00361	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00358	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00358	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00172	0.00336	CbGpPWpGaD
Dapagliflozin—ABCB1—brain—attention deficit hyperactivity disorder	0.00169	0.00346	CbGeAlD
Dapagliflozin—SLC5A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00167	0.00326	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00167	0.00326	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00165	0.00321	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SNAP25—attention deficit hyperactivity disorder	0.0016	0.00312	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00158	0.00308	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00158	0.00308	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00157	0.00306	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00156	0.00304	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00153	0.00299	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00149	0.0029	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00277	CbGpPWpGaD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00138	0.00269	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00134	0.00261	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00133	0.00259	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00128	0.0025	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00127	0.00249	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00127	0.00248	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00127	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00127	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00127	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00127	0.00247	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00127	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00125	0.00243	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00125	0.00243	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SNAP25—attention deficit hyperactivity disorder	0.00121	0.00236	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00121	0.00236	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00226	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00226	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00104	0.00202	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00103	0.00201	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.00101	0.00198	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00101	0.00198	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00101	0.00198	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00101	0.00196	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00099	0.00193	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000983	0.00192	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000979	0.00191	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000979	0.00191	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000965	0.00188	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000965	0.00188	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000963	0.00188	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000908	0.00177	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000908	0.00177	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000895	0.00175	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000879	0.00171	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000804	0.00157	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000787	0.00154	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000783	0.00153	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.00077	0.0015	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000768	0.0015	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000768	0.0015	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000763	0.00149	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000763	0.00149	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000745	0.00145	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000737	0.00144	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000732	0.00143	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000727	0.00142	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000727	0.00142	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000693	0.00135	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000678	0.00132	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000646	0.00126	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000593	0.00116	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000589	0.00115	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000579	0.00113	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000579	0.00113	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000555	0.00108	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000551	0.00107	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00055	0.00107	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000547	0.00107	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000546	0.00107	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000543	0.00106	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000543	0.00106	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000531	0.00104	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000525	0.00102	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EP300—attention deficit hyperactivity disorder	0.000519	0.00101	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000519	0.00101	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00047	0.000917	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000467	0.000911	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000464	0.000905	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000452	0.000882	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000446	0.00087	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000446	0.00087	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000442	0.000863	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000439	0.000856	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000435	0.000848	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000408	0.000796	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000405	0.000789	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EP300—attention deficit hyperactivity disorder	0.000393	0.000767	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EP300—attention deficit hyperactivity disorder	0.000393	0.000767	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000363	0.000708	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000362	0.000707	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000362	0.000707	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00036	0.000703	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000358	0.000698	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000356	0.000695	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000356	0.000695	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000339	0.000662	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000331	0.000647	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000329	0.000643	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000329	0.000643	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000305	0.000595	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000302	0.000588	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00029	0.000565	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000279	0.000545	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000279	0.000545	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000276	0.000538	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000275	0.000536	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00027	0.000527	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000268	0.000523	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000255	0.000498	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000254	0.000496	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000253	0.000493	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000241	0.00047	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000232	0.000453	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000227	0.000443	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000225	0.000439	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000223	0.000436	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.00022	0.000428	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000218	0.000425	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000213	0.000415	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000211	0.000412	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000208	0.000406	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000208	0.000406	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000205	0.000399	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000192	0.000375	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00019	0.000371	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000169	0.00033	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000168	0.000328	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000166	0.000325	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000166	0.000324	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000166	0.000324	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000164	0.000319	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.000309	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000157	0.000306	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000157	0.000306	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000155	0.000303	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000155	0.000303	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000154	0.000301	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000153	0.000298	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000152	0.000297	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000148	0.000289	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.000279	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000142	0.000277	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000133	0.000259	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000133	0.000259	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000133	0.000259	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000131	0.000255	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.000247	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000126	0.000246	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000244	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000125	0.000244	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000242	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000121	0.000237	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000237	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000233	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.000231	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000116	0.000226	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000207	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000102	0.0002	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000102	0.0002	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000197	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000101	0.000197	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000101	0.000196	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0001	0.000195	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.49e-05	0.000185	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.42e-05	0.000184	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	9.41e-05	0.000184	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	9.41e-05	0.000184	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.37e-05	0.000183	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	9.34e-05	0.000182	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.06e-05	0.000177	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.19e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	8.04e-05	0.000157	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.98e-05	0.000156	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.79e-05	0.000152	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.74e-05	0.000151	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	7.26e-05	0.000142	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.2e-05	0.000121	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.16e-05	0.00012	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.41e-05	0.000105	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.32e-05	8.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.07e-05	7.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.03e-05	7.87e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.45e-05	6.73e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.66e-05	5.19e-05	CbGpPWpGaD
